Kalliopi Dodou

Contributor

kalliopi.dodou@sunderland.ac.uk

BSc(Hons), PhD, PG Dip(HE), MRPharmS, FRSC, FHEA Senior Lecturer in Pharmaceutics, University of Sunderland, Sunderland Pharmacy School, Department of Pharmacy, Health & Well-being, Faculty of Applied Sciences, Dale Building, City campus, SR1 3SD, UK.

Concerns with using sodium valproate to treat epilepsy in pregnant women

Using sodium valproate during pregnancy can put babies at risk of developmental problems. Kalliopi Dodou and Paul Whiteley explore some of the recent evidence…

Non-coeliac gluten sensitivity — a look at the evidence behind the headlines

Is there more to the suggestion of gluten-related problems outside the classical association with coeliac disease or wheat allergy?…

Microbiomics: its growing significance in the world of medicines testing

Gut bacteria are now known to do more than just digest food. Kalliopi Dodou and Paul Whiteley take a look at microbiomics in our latest science article.…

Cognitive enhancers: what they are, how they work and what is in the pipeline

Our science series contributors Kalliopi Dodou and Hamde Nazar take a look at the cognitive enhancers currently available and research and development in this area.…

DNA not necessarily your destiny? The role of epigenetics in pharmacy

Our 2013 science series will look at the “new” pharmaceutical sciences that are emerging. Kalliopi Dodou and Paul Whiteley introduce epigenetics in this first article.…

Exploring the unconventional routes — rectal and vaginal dosage formulations

Although rectal and vaginal routes of drug delivery are not common, Kalliopi Dodou examines the design of new formulations that allow easier insertion and retention.…